Deco-Mica (531227)
CyclicalScore breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹95 |
| Market Cap | ₹41.38 Cr |
| P/E Ratio | 16.69 |
| ROCE | 11.82% |
| ROE | 6.06% |
| Dividend Yield | 0% |
| Profit Growth | -34.07% |
| Debt/Equity | — |
| Sales Growth | -16.58% |
| 52-Week Range | ₹51.24 — ₹95 |
| Sector | Chemicals & Petrochemicals |
| Book Value | ₹59.22 |
Strengths
- ROCE of 11.82% suggests existing capital employed is generating a double-digit operating return.
- Latest quarter is profitable with ₹17 Cr sales and ₹1 Cr net profit.
- P/B of 1.60 with book value ₹59.22 provides some asset support at a microcap price.
- Simple, understandable commodity chemicals business is relatively easy to monitor.
Concerns
- Sales growth has declined 16.58% and profit growth has fallen 34.07%.
- ROE of only 6.06% means shareholder capital is not compounding effectively.
- Piotroski F-score of 3/9 indicates weak financial fundamentals.
- No dividend means minority shareholders receive no income while waiting for a recovery.
AI Analysis
When I look at Deco-Mica, I see a small commodity-chemicals player, and in my experience commodities rarely create durable wealth. The numbers reinforce that. Sales have shrunk 16.58% and profits have fallen 34.07%. A P/E of 16.69 on falling earnings is not a bargain; it is a hope. At a market cap of ₹41 Cr, this is a microcap, and microcaps can be volatile and unforgiving for minority shareholders. Graham would want a margin of safety. Book value is ₹59.22, so at ₹95 the stock trades at 1.6 times book. But book value only matters if capital earns a fair return. ROE is just 6.06%, and the Piotroski F-score of 3 out of 9 signals deteriorating financial health. The business does earn an ROCE of 11.82%, which is not terrible, but on shrinking sales it is not compounding. There is no dividend, so the investor receives no cash while waiting for a turnaround. The latest quarter sales of ₹17 Cr and net profit of ₹1 Cr show the operations are still profitable, but one quarter does not make a trend. Commodity chemicals are cyclical; current weakness may be temporary. Still, I would not pay 16.7 times earnings for a business whose sales and profits are falling. If Mr. Market pushes the price down close to book value and the F-score improves, this could become more interesting. For now, the risk/reward is not in my favor. I prefer a wonderful business at a fair price, or a fair business at a wonderful price; this is neither.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer